Literature DB >> 9580861

Pulmonary embolism exclusion: a practical approach to low probability using the PIOPED data. Prospective Investigation of Pulmonary Embolism Diagnosis.

H W Gray1, R G Bessent.   

Abstract

A recent trend among physicians is the categorisation of lung scans as normal [excludes pulmonary embolism (PE)], high probability (confirms PE) and non-diagnostic (no judgement on PE risk). The low probability scan is therefore being eliminated as a functional category. This occasional survey contends that such an approach is misguided. Correction of the original PIOPED data with certain assumptions provides a more reproducible, albeit restricted, low probability scan category which excludes PE in 97% of cases in the low pre-test clinical category. Patients with a low probability scan with risk factors for PE (i.e. medium clinical risk) will require further investigation. More important, the very low probability scan category excludes PE in 98% of patients with low and more than 92% of patients with medium pre-test clinical likelihood. The demise of "low probability" is premature.

Entities:  

Mesh:

Year:  1998        PMID: 9580861     DOI: 10.1007/s002590050228

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  3 in total

1.  VQ scintigram in the CT pulmonary angiogram era.

Authors:  James D Birchall
Journal:  Eur Radiol       Date:  2005-10-11       Impact factor: 5.315

2.  Diagnosing venous thromboembolism in pregnancy.

Authors:  Thomas Grüning; Rebecca E Mingo; Matthew G Gosling; Sally L Farrell; Brent E Drake; Robert J Loader; Richard D Riordan
Journal:  Br J Radiol       Date:  2016-04-08       Impact factor: 3.039

3.  The impact of patient self-testing of prothrombin time for managing anticoagulation: rationale and design of VA Cooperative Study #481--the Home INR Study (THINRS).

Authors:  David B Matchar; Alan K Jacobson; Robert G Edson; Philip W Lavori; Jack E Ansell; Michael D Ezekowitz; Frederick Rickles; Lou Fiore; Kathy Boardman; Ciaran Phibbs; Stephan D Fihn; Julia E Vertrees; Rowena Dolor
Journal:  J Thromb Thrombolysis       Date:  2005-06       Impact factor: 2.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.